Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders (SSAS)

September 21, 2023 updated by: University of Nebraska

Comparing Recidivism Rates of Felony Drug Offenders in Nebraska Who Were Sentenced to, and/or Participated in, Specialized Substance Abuse Supervision (SSAS) to Those Without SSAS

This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who did not participate in SSAS.

Study Overview

Detailed Description

Since March 2006, Specialized Substance Abuse Supervision (SSAS) has been available at five sites in Nebraska as an enhancement of probation and parole for felony drug offenders whose scores on initial screening instruments warrant such placement. SSAS enhancements to traditional probation and parole include cognitive behavioral therapy (CBT) in groups; use of incentives; positive reinforcement; and motivational interviewing.

Records of probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 were studied to assess recidivism rates. Recidivism for this study is defined as "an arrest and conviction on a new charge while on probation or parole."

The records of a matched control group of non-SSAS probationers and parolees who entered probation or parole during the same time period with similar drug felony offenses and similar screening scores were also studied. Control group was also matched, as much as possible, with similar age group, demographic data, rural/urban residence, and level of felony offense.

Investigators performed a statistical analysis to determine recidivism rates at six months post-entrance to SSAS (and for the control group, at six months post-entrance to probation or parole).

Study Type

Observational

Enrollment (Actual)

344

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nebraska
      • Omaha, Nebraska, United States, 68198
        • University of Nebraska Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 at any of the five participating SSAS sites in Nebraska, plus matched sets of probationers and parolees who did not participated in SSAS at any of the probation/parole sites in the state of Nebraska.

Description

Inclusion Criteria:

  • convicted felony drug offender
  • sentenced in Nebraska
  • probationer or parolee
  • entered probation or parole or SSAS between March 1, 2006 and February 28, 2007

Exclusion Criteria:

  • convicted felony drug offender sentenced in Nebraska starting probation or parole between March 1, 2006 and February 28, 2007 who does not match SSAS probationers/parolees in terms of age, demographics, urban v. rural residence, and/or class of felony drug offense.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recidivism
Time Frame: 6 months
Proportion of individuals who re-offend during the six months following sentencing
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probation Violation
Time Frame: 6 months
Percentage of individuals who violated probation during the six months following sentencing
6 months
Probation violation with incarceration
Time Frame: 6 months
Percentage of individuals who violated probation and were incarcerated during the six months following sentencing
6 months
Positive drug screens
Time Frame: 6 months
Percentage of individuals with positive drug screens during the six months following sentencing
6 months
Employed
Time Frame: 6 months
Percentage of individuals employed during the six months following sentencing
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathleen M Grant, MD, University of Nebraska

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2008

Primary Completion (Actual)

July 6, 2008

Study Completion (Actual)

August 20, 2008

Study Registration Dates

First Submitted

May 6, 2008

First Submitted That Met QC Criteria

May 30, 2008

First Posted (Estimated)

June 4, 2008

Study Record Updates

Last Update Posted (Actual)

September 25, 2023

Last Update Submitted That Met QC Criteria

September 21, 2023

Last Verified

September 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-related Disorders

Clinical Trials on Specialized Substance Abuse Supervision (SSAS)

3
Subscribe